Group One Trading’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Group One Trading’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$107	–	8396
2023 Q3	$107	Hold	100	–	–	﹤0.01%	7473
2023 Q2	$259	Sell	100 -1,900	-95%	-$6.78K	﹤0.01%	7443
2023 Q1	$8.16K	Buy	+2,000	New	+$9.24K	﹤0.01%	6049
2022 Q1	–	Sell	-1,100	Closed	-$19K	–	8933
2021 Q4	$19K	Buy	1,100 +800	+267%	+$15.3K	﹤0.01%	7020
2021 Q3	$6K	Sell	300 -600	-67%	-$13.2K	﹤0.01%	7707
2021 Q2	$18K	Buy	+900	New	+$21.1K	﹤0.01%	7265

Group One Trading's NGM Position: Q2 2024 in Review

Group One Trading sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 1,052 shares — an estimated $1.67K sold.

Group One Trading first reported a position in NGM in Q3 2020 and held it in 7 quarters. The position peaked at $56K in Q3 2022. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Group One Trading reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Group One Trading sold 1,052 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.67K.
Group One Trading first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Group One Trading's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $56K in Q3 2022.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.